Part 2: Biopharma Leaders Can Use AI to Unlock Japanese Talent
In Part 1, We explored how unmanaged generative AI use in Japanese pharmaceutical affiliates can hide risk rather than reduce it, allowing employees to deliver polished work while overlooking critical market realities.
However, when deployed with clear intent and structured boundaries, AI can do the exact opposite. It can become the single most effective tool for overcoming the psychological and linguistic barriers that keep Japanese talent silent in global meetings.
As Stanford’s Matt Abrahams shared on HBR IdeaCast: “Using AI is a way to jumpstart thinking about communication. It is a great way when you’re staring at a blank screen to get yourself started… as a thought partner when you have some ideas and have it help you to coalesce those ideas, to look for themes.”
For foreign leaders in Japan, the goal is to transform AI from a public shield into a private sandbox. This may be perfect for Japanese, its safe, no need for embarrassment, failure is OK.
The Bridge: Using AI as a Private “Sandpit”
In a biopharma company, asking a Japanese Regulatory Manager or Commercial Director to challenge a global strategy during a live Teams call can feel like asking them to step onto a high wire without a safety net. The fear of being wrong in front of peers or senior leaders often freezes contribution entirely.
AI changes that equation by lowering the cost of failure before a single word is spoken publicly.
- A Low-Stakes Sparring Partner: In traditional management, pushing a local team member to debate an idea can trigger anxiety. Using AI as a private sparring partner allows Japanese managers to test controversial hypotheses such as challenging a global trial protocol or proposing an unorthodox PMDA pricing strategy in total privacy. They can stress-test their logic against an AI model first, removing the fear of immediate public judgment.
- Refining Structural Logic Japanese business communication traditionally builds extensive contextual background before reaching a conclusion (Kishōtenketsu). Western pharmaceutical leaders, by contrast, expect bottom-line-first recommendations ( Problem Insight Action). Japanese staff can use AI as a structural translator, taking complex, context-heavy local data and converting it into the direct, high-impact frameworks foreign executives expect.
- Eliminating Cognitive Friction: Translating intricate pharmaceutical concepts, local regulatory nuances, and market-access arguments into fluent business English requires immense effort. AI handles the linguistic mechanics, freeing Japanese executives to focus 100% of their energy on strategic intent.
The Leadership Playbook: Setting AI Etiquette in Pharma
Harvard Business School Professor Amy Edmondson, who pioneered the research on psychological safety, notes:
“Psychological safety is not about being nice. It’s about giving candid feedback, openly admitting mistakes, and learning from each other.”
To build this culture in Japan using AI, leaders must set clear rules of engagement:
1. Enforce the “Brian Halligan Rule”
Quoting HubSpot co-founder Brian Halligan, Wade Foster emphasizes on HBR IdeaCast: “You can delegate the work, but you can’t delegate the accountability.” Leaders must make it clear that while AI can draft a launch framework or synthesize trial notes, the local manager personally owns the recommendations. They must be prepared to defend the why behind the numbers during live discussions.
2. Reward the “Human Delta”
Explicitly tell your team that AI-generated structure is welcome, but their performance will be evaluated on the Human Delta the unique local context, PMDA rapport, physician relationship, or market intuition that no AI model could possibly know.
3. Role-Model Responsible AI Use
Executives must lead by example. Share how you use AI to test ideas or organize complex data, but be transparent about its limits. When staff see leaders using AI as a thought-starter rather than an oracle, they feel empowered to do the same.
Conclusion
AI will not automatically solve the cross-cultural communication gap in Japan’s biopharma sector it will simply expose where your workplace culture stands.
If foreign leaders govern through pressure, AI will become a shield for passive compliance. But if leaders establish clear etiquette and foster true psychological safety, AI becomes the launchpad: a private sparring partner that gives Japanese leaders the confidence, structure, and voice to lead on the global stage.
If you’re looking to build teams in Japan that can communicate with confidence and make an impact globally, let’s discuss how we can support your hiring needs. Book a discovery session with us today!
Read Part 1 first: Why Generative AI Could Make Your Local Team Even Quieter
